Back to UBS Group AG UBS Group AG

RNACRNAC
Showing 8 of 9 quarters

Position history for UBS Group AGUBS Group AG's holdings in CARTESIAN THERAPEUTICS INC

UBS Group AG holds 208,647 shares of RNAC (CARTESIAN THERAPEUTICS INC), worth $2.2M as of 2026-Q2. The position was increased (+52.5% shares). RNAC represents 0.0% of UBS Group AG's portfolio.

Current Value

$2.2M

Current Shares

208,647

Total Value Change

+$2.1M

Total Shares Change

+203,308

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
208,647
+52.5%
$2.2M0.0%$10.42
36
2026-Q1
Increased
136,840
+103.2%
$841,5660.0%$7.48
40
2025-Q4
Increased
67,341
+576.9%
$485,5280.0%$6.94
39
2025-Q3
Decreased
9,948
-24.7%
$101,6680.0%$9.85
0
2025-Q2
Decreased
13,206
-57.6%
$137,2100.0%$10.68
0
2025-Q1
Increased
31,118
+77.0%
$410,1350.0%$14.54
36
2024-Q4
Increased
17,580
+229.3%
$314,8580.0%$18.76
38
2024-Q3
Increased
5,339
+138.7%
$86,0650.0%$17.00
24

Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used